OcrelizumabPsychiatric syndrome: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1776卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70502-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：344 / 344

相关论文

共 50 条

[21] TretinoinDifferentiation syndrome: 2 case reports
Reactions Weekly, 2015, 1567 (1) : 204 - 204
[22] PhenobarbitalEMPACT syndrome: 2 case reports
Reactions Weekly, 2013, 1463 (1) : 29 - 29
[23] MetronidazoleCerebellar syndrome: 2 case reports
Reactions Weekly, 2010, 1287 (1) : 31 - 31
[24] TamoxifenAntiphospholipid syndrome: 2 case reports
Reactions Weekly, 2017, 1640 (1) : 335 - 335
[25] DapsoneHypersensitivity syndrome: 2 case reports
Reactions Weekly, 2016, 1589 (1) : 79 - 79
[26] DocetaxelErythrodysaesthesia syndrome: 2 case reports
Reactions Weekly, 2003, 947-948 (1) : 8 - 8
[27] CytarabineMyelodysplastic syndrome: 2 case reports
Reactions Weekly, 2016, 1629 (1) : 94 - 94
[28] AzathioprineHypersensitivity syndrome: 2 case reports
Reactions Weekly, 2019, 1761 (1) : 72 - 72
[29] AntitubercularsDRESS syndrome: 2 case reports
Reactions Weekly, 2021, 1865 (1) : 71 - 71
[30] CarbamazepineDRESS syndrome: 2 case reports
Reactions Weekly, 2012, 1420 (1) : 17 - 17

← 1 2 3 4 5 →